Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples